BI754111 & BI754091/BI75411 combination
Research payments
$4,603,544
Through program year 2024, $4,603,544 in research payments was reported against BI754111 & BI754091/BI75411 combination, across 951 payments.
- Paid by (largest first)
- Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co.KG
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $11,939 | 1 |
| 2021 | Research | $220,189 | 103 |
| 2020 | Research | $1,319,567 | 710 |
| 2019 | Research | $3,051,849 | 137 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Melissa Johnson Nashville, TN Named on 507 payments
- Manish Patel Sarasota, FL Named on 200 payments
- Susanna Ulahannan Ponca City, OK Named on 122 payments
- Ben George Milwaukee, WI Named on 96 payments
- Martin Gutierrez Hackensack, NJ Named on 20 payments
- Wylie Hosmer Southington, CT Named on 2 payments
- Albert Lockhart Miami, FL Named on 2 payments
- Eric Schaefer Fayetteville, AR Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.